Teva Pharmaceutical Industries has appointed Richard Francis as president and CEO, effective January 1, 2023. He replaces Kåre Schultz who will retire effective December 31, 2022, following 17 years as…
Teva Pharmaceutical Industries has appointed Richard Francis as president and CEO, effective January 1, 2023. He replaces Kåre Schultz who will retire effective December 31, 2022, following 17 years as…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


